Plasma bile acids are not associated with energy metabolism in humans.
about
Bile acids, obesity, and the metabolic syndromeCationic Polystyrene Resolves Nonalcoholic Steatohepatitis (NASH), Obesity, and Metabolic Disorders by Promoting Eubiosis of Gut Microbiota and Decreasing Endotoxemia.Fasting serum taurine-conjugated bile acids are elevated in type 2 diabetes and do not change with intensification of insulinBile acid metabolites in serum: intraindividual variation and associations with coronary heart disease, metabolic syndrome and diabetes mellitusOn the role of gallbladder emptying and incretin hormones for nutrient-mediated TSH suppression in patients with type 2 diabetesBile acid binding resin improves metabolic control through the induction of energy expenditurePhenotypic flexibility as a measure of health: the optimal nutritional stress response testMetabolic effects of cholecystectomy: gallbladder ablation increases basal metabolic rate through G-protein coupled bile acid receptor Gpbar1-dependent mechanisms in mice.Plasma bile acids show a positive correlation with body mass index and are negatively associated with cognitive restraint of eating in obese patientsBile acid metabolism and the pathogenesis of type 2 diabetes.Age-Related Changes of Plasma Bile Acid Concentrations in Healthy Adults--Results from the Cross-Sectional KarMeN Study.Appetite and body weight regulation after bariatric surgery.The TGR5 gene is expressed in human subcutaneous adipose tissue and is associated with obesity, weight loss and resting metabolic rate.The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation.Insulin Resistance is Associated With Total Bile Acid Level in Type 2 Diabetic and Nondiabetic Population: A Cross-Sectional Study.Surgical weight loss: impact on energy expenditure.The bile acid membrane receptor TGR5: a novel pharmacological target in metabolic, inflammatory and neoplastic disorders.The role of bariatric surgery in the treatment of type 2 diabetes: current evidence and clinical guidelines.Endogenous ways to stimulate brown adipose tissue in humans.Bile acid sequestrants: glucose-lowering mechanisms and efficacy in type 2 diabetes.Bile acid effects are mediated by ATP release and purinergic signalling in exocrine pancreatic cells.Mechanisms of Action of Surgical Interventions on Weight-Related Diseases: the Potential Role of Bile Acids.Colestilan decreases weight gain by enhanced NEFA incorporation in biliary lipids and fecal lipid excretion.Identification of Tetrahydropyrido[4,3-d]pyrimidine Amides as a New Class of Orally Bioavailable TGR5 AgonistsUrinary bile acids as biomarkers for liver diseases II. Signature profiles in patients.Fasting plasma chenodeoxycholic acid and cholic acid concentrations are inversely correlated with insulin sensitivity in adults.Dysregulation of Δ4-3-oxosteroid 5β-reductase in diabetic patients: Implications and mechanisms.Effect of bile acid sequestrants on glucose metabolism, hepatic de novo lipogenesis, and cholesterol and bile acid kinetics in type 2 diabetes: a randomised controlled study.
P2860
Q27020976-A2BC3A7E-D066-4415-A495-115CCD5B0AAAQ30401402-AC9368B6-11A4-4005-8C55-F9E120C61958Q33570050-FB9138BD-9F17-493C-8997-4F57EA4DF66CQ34081372-E9A24576-68B8-4FAB-8CE4-B785D383EDE1Q34363662-A752BF98-BA96-44C3-B915-8E4FD20D1E55Q34404599-572B4534-A077-4711-8214-AE28848CD47FQ35501633-2901D546-83E4-4F78-8826-8E265F645AC0Q35571329-1FC63505-DDE1-454D-AC7F-321154BAD4C7Q35675825-22D2A4CE-6A6C-4F6A-AEB0-68EEC0003869Q35917864-8BB386B6-5476-42C8-ADD7-B5D49AC43409Q35993511-A608E46B-4128-4941-9212-A6789F196986Q36669384-C17A53EE-562E-40F0-8EBB-BF568983C0C9Q36803996-7D287352-9315-433C-A965-36863B4A04EFQ36832832-C3DB7012-A98E-4515-BE92-237226ED6B6BQ37206952-1AE183E7-19EE-4919-ADA0-E9B1141621EAQ37506168-857A4921-59A5-4CD6-9D21-F99484665EF0Q38115636-A9717279-A4B3-42AD-9618-576A83A5D0D6Q38146960-4884D694-F30C-4CB5-9E3F-5B0EA4E30F7FQ38187493-0016C7B8-060B-4EF7-9F26-9818500DB5A6Q38195530-B08B66D0-0BD0-4639-8573-592555331BFCQ38866694-3751A43C-8A2A-45D4-BCC7-7538D168F580Q39090294-3E8916CF-AE7C-40B8-9D23-938C3A1DA94FQ39741648-51E9E348-E152-4319-BBB6-65A3F3B7634DQ39780596-EA8ECF08-5E66-4568-9FF3-F00F17342FA1Q42703776-D786AEEC-94FF-446D-956E-EF08632B1389Q42841701-762E0087-F443-4793-B0B1-FA60A209178DQ50099673-E42AC70C-EB8E-48A4-B0EE-6133BEF364ABQ51364519-C9F2ADF1-F60E-4DD7-BCE3-A0BD7E7BDA85
P2860
Plasma bile acids are not associated with energy metabolism in humans.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Plasma bile acids are not associated with energy metabolism in humans.
@ast
Plasma bile acids are not associated with energy metabolism in humans.
@en
Plasma bile acids are not associated with energy metabolism in humans.
@nl
type
label
Plasma bile acids are not associated with energy metabolism in humans.
@ast
Plasma bile acids are not associated with energy metabolism in humans.
@en
Plasma bile acids are not associated with energy metabolism in humans.
@nl
prefLabel
Plasma bile acids are not associated with energy metabolism in humans.
@ast
Plasma bile acids are not associated with energy metabolism in humans.
@en
Plasma bile acids are not associated with energy metabolism in humans.
@nl
P2093
P2860
P356
P1476
Plasma bile acids are not associated with energy metabolism in humans.
@en
P2093
Elizabeth J Murphy
Folkert Kuipers
Frans Stellaard
Gemma Brufau
Johann Ockenga
Klaus Hw Böker
Kris Prado
Matthias J Bahr
Michael P Manns
Thierry Claudel
P2860
P2888
P356
10.1186/1743-7075-7-73
P50
P577
2010-09-03T00:00:00Z
P5875
P6179
1001786249